Notificação de entrada na fase nacional - PCT
#1.3
09/30/2025
RPI 2856
Application data
Number
112025006165Type
Filing
Publication
PCT
US2023075163 Examination has not been requested yet. Without that request by 09/26/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:09/26/2026(32 days left)
Latest action published by the INPI: 09/30/2025. We update with every new RPI gazette, published weekly.
Applicants
FERRING B.V.
NL
Inventors
G. H. (pessoa física)
US
H. Q. (pessoa física)
US
S. B. (pessoa física)
US
IPC Classification
Priority claims
US
63/378,010 · 09/30/2022
US
63/432,974 · 12/15/2022
US
63/471,712 · 06/07/2023
Abstract
AGONISTA-ANTAGONISTA MISTO DO RECEPTOR DE VASOPRESSINA PARA MODULAR PRESSÃO ARTERIAL MÉDIA. A presente invenção refere-se a composições, tais como adequadas para administração subcutânea, e métodos para modular pressão arterial média (MAP) em um indivíduo usando um agonista-antagonista misto do receptor de V1A.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
09/30/2025
RPI 2856
#1.1
04/08/2025
RPI 2831
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.